Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2003
12/31/2003WO2003087308A3 Use of interleukin-24 to treat ovarian cancer
12/31/2003WO2003087137A3 New therapeutic uses of tri-, tetra-, penta-, and polypeptides
12/31/2003WO2003087070A3 Growth hormone secretagogues
12/31/2003WO2003076658A3 A susceptibility gene for late-onset idiopathic parkinson's disease
12/31/2003WO2003075839A3 Methods of inducing terminal differentiation
12/31/2003WO2003074675A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
12/31/2003WO2003074076A3 Periocular drug delivery for diabetic retinopathy
12/31/2003WO2003073918A3 Prevention of recurrence and metastasis of cancer
12/31/2003WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/31/2003WO2003072128A3 Methods and compositions for treating bone or cartilage defects
12/31/2003WO2003072059A3 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
12/31/2003WO2003072039A3 Cosmetic formulations containing l-arginine oligomers
12/31/2003WO2003070017A3 Novel soy protein products
12/31/2003WO2003070007A3 Method for manufacturing beads containing exogenous soy protein
12/31/2003WO2003068939A3 Cks1 INHIBITORS
12/31/2003WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia
12/31/2003WO2003068165A3 Angiopoietin-1 in the treatment of disease
12/31/2003WO2003066814A3 Peptide-dependent upregulation of telomerase expression
12/31/2003WO2003064607A3 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
12/31/2003WO2003064471A3 Gene for peripheral arterial occlusive disease
12/31/2003WO2003063775A3 Methods and compositions for the promotion of hair growth utilizing actin binding peptides
12/31/2003WO2003061728A3 Oral administration of interferon-tau
12/31/2003WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
12/31/2003WO2003057203A3 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours
12/31/2003WO2003055916A3 Adiponectin fragments and conjugates
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003053413A3 Sustained-release compositions
12/31/2003WO2003051909A3 Process for the manufacture of pharmaceutically acceptable salts of a compound
12/31/2003WO2003051334A3 Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support
12/31/2003WO2003045997A3 Fusion proteins containing tlp peptides
12/31/2003WO2003041640A3 METHODS FOR TREATING ISCHEMIC REPERFUSION INJURY USING IkB KINASE-BETA INHIBITORS
12/31/2003WO2003040301A3 Cell cycle progression proteins
12/31/2003WO2003037265A3 Method of treating viral infections
12/31/2003WO2003035004A9 Immunotherapy for reversing immune suppression
12/31/2003WO2003033667A3 Use of mx gtpases in the prognosis and treatment of cancer
12/31/2003WO2003029814A3 Neuropilin/vegf c/vegfr 3 materials and methods
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003006492A3 Biologically active peptides
12/31/2003WO2002101232A3 Bace interacting proteins
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002067971A3 Use of endostatin in the treatment of ocular neovascularization
12/31/2003WO2002064796A3 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use
12/31/2003WO2002053701A9 Epididymal lipocalin gene and uses thereof
12/31/2003WO2002050111A9 Isolated laminin 10
12/31/2003WO2002043750A8 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
12/31/2003WO2002043578A3 Determination of risk and treatment of complications of prematurity
12/31/2003WO2002042444A3 Fungal gene cluster associated with pathogenesis
12/31/2003WO2002040718A3 Method to identify genes associated with chronic myelogenous leukemia
12/31/2003WO2002040650A3 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
12/31/2003WO2002031198A3 Cancer-linked genes as targets for chemotherapy
12/31/2003WO2001064710A8 Sulfated ccr5 peptides for hiv-1 infection
12/31/2003WO2000043409A3 Alpha-conotoxin peptides
12/31/2003CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
12/31/2003CN1464791A Compositions for protein delivery via the pulmonary route
12/31/2003CN1464790A T cell receptor fusions and conjugates and methods of use thereof
12/31/2003CN1464058A Tumor-repressed fusion protein, its encoding gene and use thereof
12/31/2003CN1464057A Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function
12/31/2003CN1464053A New polypeptide-Glycosyl 12 and polynucleotides for coding same
12/31/2003CN1464052A New polypeptide-human RNA uncoiling enzyme 95 and polynucleotides for coding same
12/31/2003CN1464051A Herpesvirus thymine deoxyriboside kinase mutant and use thereof
12/31/2003CN1464049A New polypeptide-human sailer transposase 11 and polynucleotides for coding same
12/31/2003CN1463984A Medicinal collagen material and its making process
12/31/2003CN1463746A Micro-emulsified pre-concentration oral solution containing Ciclosporin A
12/31/2003CN1463745A Replenisher containing complete nutrescin
12/31/2003CN1132845C Improved method for obtaining isulin precursor having correctly-bonded cystine bond
12/31/2003CN1132818C 用作抗病毒剂的4－氧代－1,4－二氢－3－喹啉甲酰胺 As antiviral agents 4-oxo-1,4-dihydro-3-quinoline carboxamide
12/31/2003CN1132626C Stabilised growth hormone formulation and method of preparation thereof
12/31/2003CN1132625C 包胶在透明质酸微粒中的缓释药物组合物 Hyaluronic acid particles encapsulated in a sustained-release pharmaceutical compositions
12/31/2003CN1132624C Compsns. comprising antifungal agent and acetate buffer
12/31/2003CN1132586C Immunomodulating compositions from bile
12/31/2003CN1132578C Use of dipeptidyl peptidase IV inhibitors for lowering the blood glucose level mammals
12/31/2003CN1132577C Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
12/31/2003CN1132557C 靶向局部治疗疾病的装置 Targeting apparatus topical treatment of diseases
12/31/2003CA2715558A1 Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome
12/31/2003CA2530108A1 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof
12/31/2003CA2499709A1 Method for diagnosis of colorectal tumors
12/31/2003CA2495395A1 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
12/31/2003CA2492051A1 Biosynthesis of hif
12/31/2003CA2491803A1 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
12/31/2003CA2491196A1 Materials and methods for inductions of immune tolerance
12/31/2003CA2491038A1 Dna sequence and recombinant production of the grass pollen allergen phl p4
12/31/2003CA2490746A1 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation
12/31/2003CA2490636A1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs
12/31/2003CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490360A1 Pegylated factor vii glycoforms
12/31/2003CA2490342A1 Stabilised solid compositions of factor vii polypeptides
12/31/2003CA2490232A1 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
12/31/2003CA2490124A1 Scaffolded maleimide clusters for multivalent peptide assembly
12/31/2003CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003CA2489997A1 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
12/31/2003CA2489943A1 Methods for preventing and treating microbial infections by modulating transcription factors
12/31/2003CA2489930A1 Methods and means to promote gut absorption
12/31/2003CA2489905A1 Osteopontin, oligodendrocytes and myelination
12/31/2003CA2489873A1 Ace2 activation for treatment of hypertension, heart, lung and kidney disease
12/31/2003CA2489561A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same
12/31/2003CA2489348A1 Apo-2 ligand/trail variants and uses thereof
12/31/2003CA2489024A1 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/31/2003CA2488534A1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/31/2003CA2487716A1 Pharmaceutical composition for the intranasal application containing selected cgrp antagonists derived from amino acids and process for preparing them
1 ... 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 ... 3163